Inventor · disambiguated record
Michael De Vivo
Also filed as: DE VIVO MICHAEL
7 granted patents·12 pending applications·81 citations·filing 1996–2024
85Inventor score
Files withBIOXCEL THERAPEUTICS INC6MEMORY PHARM CORP6ALLELIX NEUROSCIENCE INC4DE VIVO MICHAEL1SCHUMACHER RICHARD A1
Top patents by PatentIndex Score
19 records- 0187US6699890B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Mar 2, 2004·21 cites·75 claims
- 0284US7358057B2QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cellsMEMORY PHARM CORP·Filed 2003·Granted Apr 15, 2008·14 cites·35 claims
- 0375US2025228833A1Methods and compositions for treating agitationBIOXCEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0474US6162824ATricylic amino-acid derivativesALLELIX NEUROSCIENCE INC·Filed 1999·Granted Dec 19, 2000·17 cites·19 claims
- 0568US6166072AAmino acid derivativesALLELIX NEUROSCIENCE INC·Filed 1999·Granted Dec 26, 2000·12 cites·25 claims
- 0664US2024139169A1Methods and compositions for treating agitationBIOXCEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0759US2025319069A1Methods for treating depressive statesBIOXCEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0859US2009069361A1Methods of treatment using (+)- isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2, 6-dimethyl-pyridine-3, 5-dicarboxylateMEMORY PHARM CORP·Filed 2008·Application pending·0 cites
- 0958US7205320B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Apr 17, 2007·2 cites·71 claims
- 1058US5824486AGlycine transporter-transfected cells and uses thereofALLELIX NEUROSCIENCE INC·Filed 1996·Granted Oct 20, 1998·10 cites·16 claims
- 1156US2024024289A1Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochlorideBIOXCEL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1255US2011046146A9Phosphodiesterase 4 inhibitorsSCHUMACHER RICHARD A·Filed 2006·Application pending·0 cites
- 1350US2008026081A1Methods of Treatment Using (+)-Isopropyl 2-Ethoxyethyl-4-(2-Chloro-3-Cyano-Phenyl)-1,4-Dihydro-2,6-Dimethyl-Pyridine-3,5-DicarboxylateUNTERBECK AXEL·Filed 2004·Application pending·0 cites
- 1449US5968823AGlycine transporter-transfected avian cells and uses thereofALLELIX NEUROSCIENCE INC·Filed 1998·Granted Oct 19, 1999·5 cites·20 claims
- 1548US2022395222A1Systems and methods for detection and prevention of emergence of agitationBIOXCEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1647US2022202373A1Systems and methods of using machine learning to detect and predict emergence of agitation based on sympathetic nervous system activitiesBIOXCEL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1747US2003149052A1Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Application pending·0 cites
- 1846US2006272038A1Transgenic Alzheimer's mouse model vectors and uses thereofDE VIVO MICHAEL·Filed 2006·Application pending·0 cites
- 1943US2005289660A2Cyclic amp phosphodiesterase 4d7 isoforms and methods of useMEMORY PHARM CORP·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael De Vivo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →